Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ellis

Showing results (1131-1140 of 1,150) with videos related to

Pageof 115
Sort By:
IEEE Transactions on Medical Imaging|December 11, 2025
BONBID-HIE 2023: Lesion Segmentation Challenge in BOston Neonatal Brain Injury Data for Hypoxic Ischemic EncephalopathyRina Bao, Anna N Foster, Ya'nan Song, et al.
Texas Heart Institute Journal|September 17, 2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarctionJay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
American Heart Journal|August 25, 2009
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarctionJay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
Circulation Research|August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomesChristopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Circulation. Cardiovascular Genetics|February 10, 2012
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complexRobert W Davies, George A Wells, Alexandre F R Stewart, et al.
Medical Image Analysis|June 18, 2023
Towards clinical applicability and computational efficiency in automatic cranial implant design: An overview of the AutoImplant 2021 cranial implant design challengeJianning Li, David G Ellis, Oldřich Kodym, et al.
IEEE Transactions on Medical Imaging|May 3, 2021
AutoImplant 2020-First MICCAI Challenge on Automatic Cranial Implant DesignJianning Li, Pedro Pimentel, Angelika Szengel, et al.
Bioengineering (Basel, Switzerland)|November 27, 2025
A Community Benchmark for the Automated Segmentation of Pediatric Neuroblastoma on Multi-Modal MRI: Design and Results of the SPPIN Challenge at MICCAI 2023Myrthe A D Buser, Dominique C Simons, Matthijs Fitski, et al.
Anaesthesia|November 19, 2017
Defining sepsis on the wards: results of a multi-centre point-prevalence study comparing two sepsis definitionsT Szakmany, R Pugh, M Kopczynska, et al.
Intensive Care Medicine Experimental|March 19, 2021
National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis researchAsher A Mendelson, Casey Lansdell, Alison E Fox-Robichaud, et al.
Pageof 115

Showing results (1131-1140 of 1,150) with videos related to

Sort By:
Pageof 115
IEEE Transactions on Medical Imaging|December 11, 2025
BONBID-HIE 2023: Lesion Segmentation Challenge in BOston Neonatal Brain Injury Data for Hypoxic Ischemic EncephalopathyRina Bao, Anna N Foster, Ya'nan Song, et al.
Texas Heart Institute Journal|September 17, 2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarctionJay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
American Heart Journal|August 25, 2009
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarctionJay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
Circulation Research|August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomesChristopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Circulation. Cardiovascular Genetics|February 10, 2012
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complexRobert W Davies, George A Wells, Alexandre F R Stewart, et al.
Medical Image Analysis|June 18, 2023
Towards clinical applicability and computational efficiency in automatic cranial implant design: An overview of the AutoImplant 2021 cranial implant design challengeJianning Li, David G Ellis, Oldřich Kodym, et al.
IEEE Transactions on Medical Imaging|May 3, 2021
AutoImplant 2020-First MICCAI Challenge on Automatic Cranial Implant DesignJianning Li, Pedro Pimentel, Angelika Szengel, et al.
Bioengineering (Basel, Switzerland)|November 27, 2025
A Community Benchmark for the Automated Segmentation of Pediatric Neuroblastoma on Multi-Modal MRI: Design and Results of the SPPIN Challenge at MICCAI 2023Myrthe A D Buser, Dominique C Simons, Matthijs Fitski, et al.
Anaesthesia|November 19, 2017
Defining sepsis on the wards: results of a multi-centre point-prevalence study comparing two sepsis definitionsT Szakmany, R Pugh, M Kopczynska, et al.
Intensive Care Medicine Experimental|March 19, 2021
National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis researchAsher A Mendelson, Casey Lansdell, Alison E Fox-Robichaud, et al.
Pageof 115